These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23291632)

  • 21. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
    Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
    Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation.
    Mathes CM; Bueter M; Smith KR; Lutz TA; le Roux CW; Spector AC
    Am J Physiol Regul Integr Comp Physiol; 2012 Mar; 302(6):R751-67. PubMed ID: 22170618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective lack of tolerance to delayed gastric emptying after daily administration of WIN 55,212-2 in the rat.
    Abalo R; Cabezos PA; López-Miranda V; Vera G; González C; Castillo M; Fernández-Pujol R; Martín MI
    Neurogastroenterol Motil; 2009 Sep; 21(9):1002-e80. PubMed ID: 19413685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats.
    Hayes MR; Kanoski SE; Alhadeff AL; Grill HJ
    Obesity (Silver Spring); 2011 Jul; 19(7):1342-9. PubMed ID: 21415845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
    Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
    Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study.
    Mohammadi Vosough E; Baradaran Rahimi V; Masoud SA; Mirkarimi HR; Demneh MK; Abed A; Banafshe HR; Askari VR
    Life Sci; 2019 Sep; 232():116670. PubMed ID: 31330139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
    Fattore L; Cossu G; Martellotta CM; Fratta W
    Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice.
    Manzanedo C; Rodríguez-Arias M; Daza-Losada M; Maldonado C; Aguilar MA; Miñarro J
    Behav Brain Funct; 2010 Mar; 6():19. PubMed ID: 20307280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex.
    Benagiano V; Lorusso L; Flace P; Girolamo F; Rizzi A; Sabatini R; Auteri P; Bosco L; Cagiano R; Ambrosi G
    Neuroscience; 2007 Nov; 149(3):592-601. PubMed ID: 17916407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.
    Hama A; Sagen J
    Brain Res; 2011 Sep; 1412():44-54. PubMed ID: 21813113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
    Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR
    Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cannabinoid antagonist SR144528 enhances the acute effect of WIN 55,212-2 on gastrointestinal motility in the rat.
    Abalo R; Cabezos PA; Vera G; Fernández-Pujol R; Martín MI
    Neurogastroenterol Motil; 2010 Jun; 22(6):694-e206. PubMed ID: 20132133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
    Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
    Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.
    van Bloemendaal L; IJzerman RG; Ten Kulve JS; Barkhof F; Konrad RJ; Drent ML; Veltman DJ; Diamant M
    Diabetes; 2014 Dec; 63(12):4186-96. PubMed ID: 25071023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.
    Dodd GT; Mancini G; Lutz B; Luckman SM
    J Neurosci; 2010 May; 30(21):7369-76. PubMed ID: 20505104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.
    Burgos E; Gómez-Nicola D; Pascual D; Martín MI; Nieto-Sampedro M; Goicoechea C
    Eur J Pharmacol; 2012 May; 682(1-3):62-72. PubMed ID: 22374260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist exendin-4.
    Duca FA; Sakar Y; Covasa M
    Diabetes; 2013 Jul; 62(7):2410-5. PubMed ID: 23423571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous infusion of the cannabinoid WIN 55,212-2 to the site of a peripheral nerve injury reduces mechanical and cold hypersensitivity.
    Lever IJ; Pheby TM; Rice AS
    Br J Pharmacol; 2007 May; 151(2):292-302. PubMed ID: 17375083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.